PCNA and cancer: It has been demonstrated that certain cancer cells are stressed as a consequence of their genomic mutations, and it is thus possible that the total PCNA in these cells contains more of a modified PCNA with high affinity for APIM-peptides that could sensitize these cancer cells to ATX-101 treatment.